Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case report.
Eguchi S, Shinkawa H, Sato Y, Nakai K, Takemura S, Tanaka S, Amano R, Kimura K, Ohira G, Nishio K, Kinoshita M, Tauchi J, Miyazaki T, Ishihara A, Shirai D, Kubo S.
Eguchi S, et al. Among authors: miyazaki t.
Clin J Gastroenterol. 2021 Jun;14(3):858-865. doi: 10.1007/s12328-021-01396-5. Epub 2021 Apr 2.
Clin J Gastroenterol. 2021.
PMID: 33811313